References
- Abdel-Magid, A. (2015). Allosteric modulators: An emerging concept in drug discovery. ACS Medicinal Chemistry Letters, 6(2), 104–107. https://doi.org/https://doi.org/10.1021/ml5005365
- Bence, K. K., Delibegovic, M., Xue, B., Gorgun, C. Z., Hotamisligil, G. S., Neel, B. G., & Kahn, B. B. (2006). Neuronal PTP1B regulates body weight, adiposity and leptin action. Nature Medicine, 12(8), 917–924. https://doi.org/https://doi.org/10.1038/nm1435
- Bharatham, K., Bharatham, N., Kwon, Y. J., & Lee, K. W. (2008). Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling. Journal of Computer-Aided Molecular Design, 22(12), 925–933. https://doi.org/https://doi.org/10.1007/s10822-008-9229-0
- Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005). The amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. https://doi.org/https://doi.org/10.1002/jcc.20290
- Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The Lancet, 389(10085), 2239–2251. https://doi.org/https://doi.org/10.1016/S0140-6736(17)30058-2
- Colombano, G., Caldwell, J. J., Matthews, T. P., Bhatia, C., Joshi, A., McHardy, T., Mok, N. Y., Newbatt, Y., Pickard, L., Strover, J., Hedayat, S., Walton, M. I., Myers, S. M., Jones, A. M., Saville, H., McAndrew, C., Burke, R., Eccles, S. A., Davies, F. E., Bayliss, R., & Collins, I. (2019). Binding to an unusual inactive kinase conformation by highly selective inhibitors of inositol-requiring enzyme 1α kinase-endoribonuclease. Journal of Medicinal Chemistry, 62(5), 2447–2465. https://doi.org/https://doi.org/10.1021/acs.jmedchem.8b01721
- Cui, W., Cheng, Y., Geng, L., Liang, D., Hou, T., & Ji, M. (2013). Unraveling the allosteric inhibition mechanism of PTP1B by free energy calculation based on umbrella sampling. Journal of Chemical Information and Modeling, 53(5), 1157–1167. https://doi.org/https://doi.org/10.1021/ci300526u
- Cui, D. S., Lipchock, J. M., Brookner, D., & Loria, J. P. (2019). Uncovering the molecular interactions in the catalytic loop that modulate the conformational dynamics in protein tyrosine phosphatase 1B. Journal of the American Chemical Society, 141(32), 12634–12647. https://doi.org/https://doi.org/10.1021/jacs.9b04470
- Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C. C., Ramachandran, C., Gresser, M. J., Tremblay, M. L., & Kennedy, B. P. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (New York, N.Y.).), 283(5407), 1544–1548. https://doi.org/https://doi.org/10.1126/science.283.5407.1544
- Fang, L., Wang, X., Xi, M., Liu, T., & Yin, D. (2016). Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations. Molecular Biosystems, 12(4), 1174–1182. https://doi.org/https://doi.org/10.1039/C6MB00067C
- Garuti, L., Bottegoni, M., & Roberti, G. (2010). Non-ATP competitive protein kinase inhibitors. Current Medicinal Chemistry, 17(25), 2804–2821. https://doi.org/https://doi.org/10.2174/092986710791859333
- Genheden, S., & Ryde, U. (2010). How to obtain statistically converged MM/GBSA results. Journal of Computational Chemistry, 31(4), 837–846. https://doi.org/https://doi.org/10.1002/jcc.21366
- Huggins, D. J., Sherman, W., & Tidor, B. (2012). Rational approaches to improving selectivity in drug design. Journal of Medicinal Chemistry, 55(4), 1424–1444. https://doi.org/https://doi.org/10.1021/jm2010332
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
- Ito, M., Fukuda, S., Sakata, S., Morinaga, H., & Ohta, T. (2014). Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice. Journal of Diabetes Research, 2014, 680348. https://doi.org/https://doi.org/10.1155/2014/680348
- Jin, T., Yu, H., & Huang, X. (2016). Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B. Scientific Reports, 6(1), 20766. https://doi.org/https://doi.org/10.1038/srep20766
- Johnson, T. O., Ermolieff, J., & Jirousek, M. R. (2002). Protein tyrosine phosphatase 1B inhibitors for diabetes. Nature Reviews Drug Discovery, 1(9), 696–709. https://doi.org/https://doi.org/10.1038/nrd895
- Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/https://doi.org/10.1063/1.445869
- Joyce, C. M., Potapova, O., DeLucia, A. M., Huang, X., Basu, V. P., & Grindley, N. D. F. (2008). Fingers-closing and other rapid conformational changes in DNA polymerase I (klenow fragment) and their role in nucleotide selectivity. Biochemistry, 47(23), 6103–6116. https://doi.org/https://doi.org/10.1021/bi7021848
- Kamerlin, S. C. L., Rucker, R., & Boresch, S. (2007). A molecular dynamics study of WPD-loop flexibility in PTP1B. Biochemical and Biophysical Research Communications, 356(4), 1011–1016. https://doi.org/https://doi.org/10.1016/j.bbrc.2007.03.093
- Kim, Y., Lee, J.-Y., Jung, K.-W., & Woo, E.-R. (2008). Docking study of biflavonoids, allosteric inhibitors of protein tyrosine phosphatase 1B. Bulletin of the Korean Chemical Society, 29(8), 1479–1484. https://doi.org/https://doi.org/10.5012/bkcs.2008.29.8.1479
- Kulkarni, Y. S., Liao, Q., Petrović, D., Krüger, D. M., Strodel, B., Amyes, T. L., Richard, J. P., & Kamerlin, S. C. L. (2017). Enzyme architecture: Modeling the operation of a hydrophobic clamp in catalysis by triosephosphate isomerase. Journal of the American Chemical Society, 139(30), 10514–10525. https://doi.org/https://doi.org/10.1021/jacs.7b05576
- Kumar, A. P., Nguyen, M. N., Verma, C., & Lukman, S. (2018). Structural analysis of protein tyrosine phosphatase 1B reveals potentially druggable allosteric binding sites. Proteins, 86(3), 301–321. https://doi.org/https://doi.org/10.1002/prot.25440
- Kumar, R., Shinde, R. N., Ajay, D., & Sobhia, M. E. (2010). Probing interaction requirements in PTP1B inhibitors: A comparative molecular dynamics study. Journal of Chemical Information and Modeling, 50(6), 1147–1158. https://doi.org/https://doi.org/10.1021/ci900484g
- Li, S., Zhang, J., Lu, S., Huang, W., Geng, L., Shen, Q., & Zhang, J. (2014). The mechanism of allosteric inhibition of protein tyrosine phosphatase 1B. PloS One, 9(5), e97668. https://doi.org/https://doi.org/10.1371/journal.pone.0097668
- Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00255
- McGibbon, R. T., Beauchamp, K. A., Harrigan, M. P., Klein, C., Swails, J. M., Hernández, C. X., Schwantes, C. R., Wang, L. P., Lane, T. J., & Pande, V. (2015). MDTraj: A modern open library for the analysis of molecular dynamics trajectories. Biophysical Journal, 109(8), 1528–1532. https://doi.org/https://doi.org/10.1016/j.bpj.2015.08.015
- Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/https://doi.org/10.1021/ct300418h
- Nosé, S. (1984). A unified formulation of the constant temperature molecular dynamics methods. The Journal of Chemical Physics, 81(1), 511–519. https://doi.org/https://doi.org/10.1063/1.447334
- Nussinov, R., & Tsai, C. J. (2013). Allostery in disease and in drug discovery. Cell, 153(2), 293–305. doi:S0092-8674(13)00391-7 [pii] https://doi.org/https://doi.org/10.1016/j.cell.2013.03.034
- Olmez, E. O., & Alakent, B. (2011). Alpha7 helix plays an important role in the conformational stability of PTP1B. Journal of Biomolecular Structure & Dynamics, 28(5), 675–693. https://doi.org/https://doi.org/10.1080/07391102.2011.10508599
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/https://doi.org/10.1002/jcc.20084
- Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. https://doi.org/https://doi.org/10.1002/jcc.20289
- Puius, Y. A., Zhao, Y., Sullivan, M., Lawrence, D. S., Almo, S. C., & Zhang, Z. Y. (1997). Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design. Proceedings of the National Academy of Sciences of the United States of America, 94(25), 13420–13425. [pii] https://doi.org/1813
- Raza, S., Ranaghan, K. E., van der Kamp, M. W., Woods, C. J., Mulholland, A. J., & Azam, S. S. (2019). Visualizing protein-ligand binding with chemical energy-wise decomposition (CHEWD): Application to ligand binding in the kallikrein-8 S1 site. Journal of Computer-Aided Molecular Design, 33(5), 461–475. https://doi.org/https://doi.org/10.1007/s10822-019-00200-4
- Šali, A., & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3), 779–815. https://doi.org/https://doi.org/10.1006/jmbi.1993.1626
- Shinde, R. N., Kumar, G. S., Eqbal, S., & Sobhia, M. E. (2018). Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches. PloS One, 13(6), e0199020. https://doi.org/https://doi.org/10.1371/journal.pone.0199020
- Shinde, R. N., & Sobhia, M. E. (2013). Binding and discerning interactions of PTP1B allosteric inhibitors: Novel insights from molecular dynamics simulations. Journal of Molecular Graphics and Modelling, 45, 98–110. https://doi.org/https://doi.org/10.1016/j.jmgm.2013.08.001
- Singh, A., Somvanshi, P., & Grover, A. (2019). Pyrazinamide drug resistance in RpsA mutant (Δ438A) of mycobacterium tuberculosis: Dynamics of essential motions and free-energy landscape analysis. Journal of Cellular Biochemistry, 120(5), 7386–7402. https://doi.org/https://doi.org/10.1002/jcb.28013
- Tonks, N. K., Diltz, C. D., & Fischer, E. H. (1988). Purification of the major protein-tyrosine-phosphatases of human placenta. Journal of Biological Chemistry, 263(14), 6722. http://www.jbc.org/content/263/14/6722.abstract
- van Gunsteren, W. F., & Berendsen, H. J. C. (1977). Algorithms for macromolecular dynamics and constraint dynamics. Molecular Physics, 34(5), 1311–1327. https://doi.org/https://doi.org/10.1080/00268977700102571
- Wang, Q., Fu, X., & Zheng, Q. (2019). Exploring the allosteric mechanism of protein tyrosine phosphatase 1B by molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2019.1682049
- Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z. H., & Hou, T. (2019). End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chemical Reviews, 119(16), 9478–9508. https://doi.org/https://doi.org/10.1021/acs.chemrev.9b00055
- Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. https://doi.org/https://doi.org/10.1002/jcc.20035
- Wiesmann, C., Barr, K. J., Kung, J., Zhu, J., Erlanson, D. A., Shen, W., Fahr, B. J., Zhong, M., Taylor, L., Randal, M., Mcdowell, R. S., & Hansen, S. K. (2004). Allosteric inhibition of protein tyrosine phosphatase 1B. Nature Structural & Molecular Biology, 11(8), 730–737. https://doi.org/https://doi.org/10.1038/nsmb803
- Wiesmann, C., Barr, K. J., Kung, J., Zhu, J., Erlanson, D. A., Shen, W., Fahr, B. J., Zhong, M., Taylor, L., Randal, M., McDowell, R. S., & Hansen, S. K. (2004). Allosteric inhibition of protein tyrosine phosphatase 1B. Nature Structural & Molecular Biology, 11(8), 730–737. https://doi.org/https://doi.org/10.1038/nsmb803
- You-Ten, K. E., Muise, E. S., Itié, A., Michaliszyn, E., Wagner, J., Jothy, S., Lapp, W. S., & Tremblay, M. L. (1997). Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. The Journal of Experimental Medicine, 186(5), 683–693. https://doi.org/https://doi.org/10.1084/jem.186.5.683
- Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews. Endocrinology, 14(2), 88–98. https://doi.org/https://doi.org/10.1038/nrendo.2017.151